ARCA biopharma

ARCA biopharma, Inc. is a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases. ARCA’s principal focus is to develop personalized therapies for the treatment of cardiovascular disease through the use of genetics. The Company’s business focus combines expertise in cardiovascular pathophysiology, molecular genetics, and clinical development. 
Type
Public
HQ
Westminster, US
Founded
2009
Size (employees)
20 (est)
ARCA biopharma was founded in 2009 and is headquartered in Westminster, US

ARCA biopharma Office Locations

ARCA biopharma has offices in Westminster and Aurora
Westminster, US (HQ)
140 11080 Circle Point Rd
Westminster, US
11080 CirclePoint Rd Ste 140
Aurora, US
12635 E. Montview Blvd

ARCA biopharma Financials and Metrics

ARCA biopharma Financials

USD

Net income (Q1, 2017)

(4.3 m)

Market capitalization (13-Nov-2017)

11 m

Cash (31-Mar-2017)

6.2 m
ARCA biopharma's current market capitalization is $11 m.
USDFY, 2016

Net Income

(16.4 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

R&D expense

1.4 m1.3 m

General and administrative expense

1 m950 k

Operating expense total

2.4 m2.3 m

EBIT

(2.4 m)(2.3 m)
USDFY, 2016

Cash

7.4 m

Current Assets

21.4 m

PP&E

66 k

Total Assets

24.6 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

19.4 m17.2 m12.2 m44.1 m41.5 m29.7 m14.4 m8.1 m6.2 m

Current Assets

19.7 m17.5 m12.7 m44.3 m41.7 m31 m26.7 m23.8 m19.9 m

PP&E

29 k26 k34 k34 k31 k24 k76 k69 k59 k

Total Assets

20.5 m18 m13.3 m45.1 m42.4 m36.9 m32.6 m28.7 m20.6 m
USDFY, 2016

Net Income

(16.4 m)

Depreciation and Amortization

24 k

Accounts Payable

841 k

Cash From Operating Activities

(15 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(4.8 m)(7.1 m)(2.7 m)(5.5 m)(8.3 m)(3.6 m)(7.5 m)(12.2 m)(4.3 m)

Depreciation and Amortization

5 k8 k4 k9 k14 k5 k9 k17 k7 k

Accounts Payable

128 k(232 k)(144 k)(198 k)(167 k)380 k391 k648 k(234 k)

Cash From Operating Activities

(5.5 m)(7.5 m)(3.1 m)(5.5 m)(7.9 m)(3.9 m)(7.4 m)(11.1 m)(4.3 m)
Y, 2017

Financial Leverage

1.1 x
Show all financial metrics

ARCA biopharma Market Value History

ARCA biopharma's Web-traffic and Trends

ARCA biopharma Company Life and Culture

You may also be interested in